|
시장보고서
상품코드
2076103
아미트리프틸린 시장 : 강도별, 적응증별, 유통 채널별, 지역별Amitriptyline Market, By Strength, By Indication, By Distribution Channel, By geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
아미트리프틸린 시장은 2026년에 7억 1,620만 달러 규모가 된다고 추정되고 있어 2033년까지 10억 6,270만 달러에 이를 것으로 예상되고 있습니다. 2026년부터 2033년까지 CAGR 5.8%로 성장할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 7억 1,620만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간 CAGR : | 5.80% | 2033년 시장 규모 예측 : | 10억 6,270만 달러 |
아미트리프틸린은 진정 작용을 가진 삼환계 항우울제입니다. 아미트리프틸린은 뇌세포 간에 정보를 전달하며 기분 조절에 관여하는 특정 화학 전달 물질(신경 전달 물질)에 작용합니다. 이 약은 주요 우울 장애, 신경성 통증, 성인의 만성 긴장형 두통(CTTH) 및 편두통의 예방적 치료에 사용되며, 야뇨증 치료에도 사용됩니다. 정제 형태로 판매되고 있습니다.
시장 역학
우울증 및 양극성 장애의 유병률 증가로 인해 아미트리프틸린 등 삼환계 항우울제에 대한 수요가 증가할 것으로 예상되며, 이에 따라 전 세계 아미트리프틸린 시장의 성장에 기여할 것으로 전망됩니다. 세계 질병 부담 협력 네트워크(GBD)에 따르면, 2017년 양극성 장애의 유병률은 국가별로 0.3%에서 1.2% 사이였으며, 전 세계적으로 약 4,600만 명이 양극성 장애로 고통받고 있었습니다. 양극성 장애는 조증이라고도 불리는 뇌 질환으로, 기분, 에너지 수준 및 기타 활동에 영향을 미칩니다.
본 조사의 주요 특징:
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 시장 성장 억제요인, 기회, 신약 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하고 있는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 전 세계 아미트리프틸린 시장의 주요 기업 프로파일을 작성하고 있습니다. 구체적으로는 기업 개요, 재무 실적, 의약품 포트폴리오, 시장 내 입지, 유통 전략, 주요 발전 사항, 전략 및 향후 계획입니다.
- 본 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 의약품 출시, 약물 분류의 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- 본 세계 아미트리프틸린 시장 보고서는 투자자, 공급업체, 제약사, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 신경섬유종증 치료제 시장 분석에 활용된 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 아미트리프틸린 시장 : 강도별, 2021-2033년
제5장 세계의 아미트리프틸린 시장 : 적응증별, 2021-2033년
제6장 세계의 아미트리프틸린 시장 : 유통 채널별, 2021-2033년
제7장 세계의 아미트리프틸린 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
JHS 26.07.09Amitriptyline Market is estimated to be valued at USD 716.2 Mn in 2026 and is expected to reach USD 1,062.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 716.2 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.80% | 2033 Value Projection: | USD 1,062.7 Mn |
Amitriptyline is a tricyclic antidepressant with sedative effects. Amitriptyline affects certain chemical messengers (neurotransmitters) that communicate between brain cells and help to regulate the mood. The drug is indicated for treatment of major depressive disorder, neuropathic pain, the prophylactic treatment of chronic tension type headache (CTTH) and migraine in adults, also used in the treatment of nocturnal enuresis. It is available in tablet form.
Market Dynamics
Increasing prevalence of depression or bipolar disorder is expected to drive demand for tricyclic antidepressants such as Amitriptyline, thereby contributing to growth of the global amitriptyline market. According to the Global Burden of Disease Collaborative Network, in 2017, the prevalence of bipolar disorder ranged from 0.3% to 1.2% by country, and around 46 million people suffered from the bipolar disorder worldwide. Bipolar disorder is a brain disorder, also known as manic illness, which affects the mood, energy level, and other activities.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global amitriptyline market based on the following parameters - company overview, financial performance, drugs portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study are Accord Healthcare Inc., Mylan Pharmaceuticals Inc., Sandoz Inc., Sun Pharmaceutical Industries Inc., Vintage Pharmaceuticals Inc., Zydus Pharmaceuticals USA Inc., Watson laboratories Inc., and Torrent Pharmaceuticals Ltd.
- Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
- The global amitriptyline market report caters to various stakeholders in this industry including investors, suppliers, drugs manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neurofibromatosis treatment drugs market.
Detailed Segmentation:
- Global Amitriptyline Market, By Strength (Revenue, USD Mn, 2021 - 2033)
- 10 mg tablets
- 25 mg tablets
- 50 mg tablets
- 75 mg tablets
- 100 mg tablets
- 150 mg tablets
- Global Amitriptyline Market, By Indication (Revenue, USD Mn, 2021 - 2033)
- Depression
- Nocturnal Enuresis
- Migraine
- Chronic Neuropathic Pain
- Others
- Global Amitriptyline Market, By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Amitriptyline Market, By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- By Strength:
- 10 mg tablets
- 25 mg tablets
- 50 mg tablets
- 75 mg tablets
- 100 mg tablets
- 150 mg tablets
- By Indication:
- Depression
- Nocturnal Enuresis
- Migraine
- Chronic Neuropathic Pain
- Others
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country:
- U.S.
- Canada
- By Strength:
- Latin America
- By Strength:
- 10 mg tablets
- 25 mg tablets
- 50 mg tablets
- 75 mg tablets
- 100 mg tablets
- 150 mg tablets
- By Indication:
- Depression
- Nocturnal Enuresis
- Migraine
- Chronic Neuropathic Pain
- Others
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Strength:
- Europe
- By Strength:
- 10 mg tablets
- 25 mg tablets
- 50 mg tablets
- 75 mg tablets
- 100 mg tablets
- 150 mg tablets
- By Indication:
- Depression
- Nocturnal Enuresis
- Migraine
- Chronic Neuropathic Pain
- Others
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- By Strength:
- Asia Pacific
- By Strength:
- 10 mg tablets
- 25 mg tablets
- 50 mg tablets
- 75 mg tablets
- 100 mg tablets
- 150 mg tablets
- By Indication:
- Depression
- Nocturnal Enuresis
- Migraine
- Chronic Neuropathic Pain
- Others
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Strength:
- Middle East
- By Strength:
- 10 mg tablets
- 25 mg tablets
- 50 mg tablets
- 75 mg tablets
- 100 mg tablets
- 150 mg tablets
- By Indication:
- Depression
- Nocturnal Enuresis
- Migraine
- Chronic Neuropathic Pain
- Others
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country/Region:
- GCC
- Israel
- Rest of Middle East
- By Strength:
- Africa
- By Strength:
- 10 mg tablets
- 25 mg tablets
- 50 mg tablets
- 75 mg tablets
- 100 mg tablets
- 150 mg tablets
- By Indication:
- Depression
- Nocturnal Enuresis
- Migraine
- Chronic Neuropathic Pain
- Others
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- By Strength:
- Company Profiles
- Accord Healthcare Inc.*
- Company Overview
- Strength Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Mylan Pharmaceuticals Inc.
- Sandoz Inc.
- Sun Pharmaceutical Industries Inc.
- Vintage Pharmaceuticals Inc.
- Zydus Pharmaceuticals USA Inc.
- Watson laboratories Inc.
- Torrent Pharmaceuticals Ltd.
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Strength
- Market Snapshot, By Indication
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- Recent Product Launches/Approvals
- Merger, Acquisition, Collaborations Scenario
- Regulatory Scenario
- PEST Analysis
- Porter's Five Forces Analysis
- Mechanism of Action
4. Global Amitriptyline Market, By Strength, 2021 - 2033, (US$ Min)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- 10 mg tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- 25 mg tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- 50 mg tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- 75 mg tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- 100 mg tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- 150 mg tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
5. Global Amitriptyline Market, By Indication, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Depression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Nocturnal Enuresis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Migraine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Chronic Neuropathic Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
6. Global Amitriptyline Market, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
7. Global Amitriptyline Market, By Region, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Strength, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Strength, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Strength, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Min)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Strength, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
- China
- Japan
- India
- Australia
- ASEAN
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Strength, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Strength, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Mn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Accord Healthcare Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Viatris Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sandoz Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sun Pharmaceutical Industries Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Vintage Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Zydus Pharmaceuticals USA Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Watson laboratories Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Torrent Pharmaceuticals Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Dr Reddy's Laboratories Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Unichem Laboratories Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Apotex Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Intas Pharmaceuticals Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Section
- Research Methodology
- About Us
